4Lo-Coco F, Foa R. Diagnostic and prognostic advances in the immunophenotypic and genetic characterization of acute leukaemia[J]. Eur J Haematol, 1995, 55(1): 1-9.
5Bene MC, Castoldi G, Knapp W, et al. Proposals for the immunological classification of acute leukemias. Europoan Group for the Immunological Characterization of Lcukemias (EGIL) [ J ]. Leukemia, 1995, 9(10): 1783-6.
6Jennings CD, Foon KA. Recent advances in flow cytometry:, application to the diagnosis of hematologic malignancy[J]. Blood, 1997,90(8): 2863-92.
7Khalidi HS, Medeiros LJ, Chang KL, et al. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and katyotypic abnormalities[J].Am J Clin Pathol, 1998, 109(2): 211-20.
8Casasnovas RO, Slimane FK, Garand R, et al. Immunological classification of acute myeloblastic leukemias: relevance to patient outcome[J]. Leukemia, 2003, 17(3): 515-27.
9Baer MR, Stewart CC, Lawrence D, et aL Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t (8;21)(q22;q22)[J]. Blood, 1997, 90(4): 1643-8.
10Suzuki R, Nakamura S. Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia[J]. Leuk Res, 1999, 23(7): 615-24.
3[1]Ichinohasama R,DeCotean JF,Myers J,et al.Three-color flow cytometry in the diagnosis of malignant lymphomabased on the comparative cell morphology of lymphoma cells and reactive lymphocytes[J].Leukemia,1997,11(11):1891-1903.
4[5]Bene MC,Bemier M.Casasnovas RO,et al.The reliability and specificity of C-kit for the diagnosis of acute myeloid leukemias and undifferentiated leukemias[J].Blood,1998,92(2):596-599.
5[6]Kaleem Z,Crawford E,Pathan MH,et al.Flow cytometric analysis of acute leukemias.Diagnostic utility and critieal analysis of data[J].Arch Pathol Lab Med,2003,127(1):42-48.
6[7]Yang DT,Greenwood JH,Hartung L,et al.Flow cytometric analysis of different CD14 epitopes can help identify immature monocytic populations[J].Am J Clin Pathol,2005,124(6):930-936.
7[8]Auewarakul CU,Promsuwicha O,U-Pratya Y,et al.Immunophenotypic profile of adult acute myeloid leukemia(AML):analysis of 267 cases in Thailand[J].Asian Pac J Allergy Immunol,2003,21(3):153-160.
8[9]Venditti A,Del PG,Buccisano F,et al.Minimally differentiated acute myeloid leukemia(AML-M0):comparison of 25 cases with other French-American-British subtypes[J].Blood,1997,89(2):621-629.
9[10]Mason KD,Juneja SK,Szer J.The immunophenotypic of acute myeloid leukemia:is there a relationship with prognosis[J].Blood Rev,2006,20(2):71-78.
10[11]Mejstrikova E,Kalina T,Trka J,et al,Correlation of CD33 with Poorer prognosis in childhood all implicates a potential of anti-CD33 frontline therapy[J].Leukemia,2005,19(6):1092-1094.
